학술논문
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
Document Type
Article
Author
Horwitz, Steven M. ; Scarisbrick, Julia J.; Dummer, Reinhard; Whittaker, Sean; Duvic, Madeleine; Kim, Youn H.; Quaglino, Pietro; Zinzani, Pier Luigi; Bechter, Oliver; Eradat, Herbert; Pinter-Brown, Lauren; Akilov, Oleg E.; Geskin, Larisa; Sanches, Jose A.; Ortiz-Romero, Pablo L.; Weichenthal, Michael; Fisher, David C.; Walewski, Jan; Trotman, Judith; Taylor, Kerry; Dalle, Stephane; Stadler, Rudolf; Lisano, Julie; Bunn, Veronica; Little, Meredith; Prince, H. Miles
Source
In Blood Advances 14 December 2021 5(23):5098-5106
Subject
Language
ISSN
2473-9529